A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial

MLA

Safwaan Adam, et al. “A Comparison of the Effects of Low- and High-Dose Atorvastatin on Lipoprotein Metabolism and Inflammatory Cytokines in Type 2 Diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) Randomized Trial.” Journal of Clinical Lipidology, vol. 12, no. 1, May 2017. EBSCOhost, https://doi.org/10.1016/j.jacl.2017.10.011.

APA

Safwaan Adam, Paul N. Durrington, See Kwok, J. Martin Gibson, Tarza Siahmansur, Handrean Soran, Martin K. Rutter, Jan H. Ho, Naveed Younis, Matthew Gittins, Jonathan Schofield, & Yifen Liu. (2017). A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial. Journal of Clinical Lipidology, 12(1). https://doi.org/10.1016/j.jacl.2017.10.011

Chicago

Safwaan Adam, Paul N. Durrington, See Kwok, J. Martin Gibson, Tarza Siahmansur, Handrean Soran, Martin K. Rutter, et al. 2017. “A Comparison of the Effects of Low- and High-Dose Atorvastatin on Lipoprotein Metabolism and Inflammatory Cytokines in Type 2 Diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) Randomized Trial.” Journal of Clinical Lipidology 12 (1). doi:10.1016/j.jacl.2017.10.011.